Navigation Links
3-V Biosciences Commences Patient Dosing in Phase 1 Clinical Study of FASN Inhibitor TVB-2640 in Patients with Advanced Solid Tumors
Date:12/4/2013

MENLO PARK, Calif., Dec. 4, 2013 /PRNewswire/ -- 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious disease, today announced the recent initiation of a Phase 1 clinical study of TVB-2640 in patients with advanced solid tumors.  TVB-2640 is an oral, proprietary fatty acid synthase (FASN) inhibitor being evaluated for the treatment of solid tumors.  FASN is an enzyme responsible for the synthesis of palmitic acid and has a key role in tumor metabolism, lipid signaling and tumor cell survival.

(Logo: http://photos.prnewswire.com/prnh/20121001/LA83573LOGO)

"For tumors to grow, cancer cells need to process more fuel than normal cells.  The ability to interfere in tumor cell metabolism is an extremely compelling avenue for oncology drug development," said Jeffrey Infante, M.D., Sarah Cannon Research Institute in Nashville, TN and lead investigator for the 3-V clinical trial.  "TVB-2640 is the first inhibitor of FASN to enter the clinic. Our center is excited to be leading the Phase 1 clinical study for this emerging and promising anti-cancer therapy."

The Phase 1 open-label, dose-escalation trial will enroll patients with advanced solid tumors whose cancer has become refractory to standard therapy, and for whom no useful treatment exists.  Patients will receive TVB-2640 once daily for 21 days.  The primary endpoint for the Phase 1 study is the identification of any dose-limiting toxicities and the establishment of a maximum-tolerated dose (MTD) for oral TVB-2640.  Secondary and exploratory endpoints include safety, pharmacokinetics, and initial signs of efficacy and evidence of FASN biomarker activity.

"With the initiation of this Phase 1 clinical trial, we look f
'/>"/>

SOURCE 3-V Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit Biosciences Provides Regulatory Update Following FDA Meeting Regarding Quizartinib (AC220)
2. Neodyne Biosciences Announces Issuance of U.S. Patent for Devices and Methods for Dressing Applicators
3. ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy
4. 3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
5. Lilly Statement on Contribution to Indiana Biosciences Research Institute
6. Indiana Biosciences Research Institute Hits $50 Million Start-Up Funding Goal
7. Regado Biosciences, Inc. Adds Global Pharmaceutical Business Veteran to Board of Directors
8. Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
9. Regado Biosciences, Inc. Announces Third Quarter 2013 Results
10. ViGene Biosciences Introduces Worlds Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
11. Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014 Pharmaceutical Care Management ... today outlined policy solutions that could reduce prescription fraud ... Hill briefing, " Prescription Opioid Abuse: Fighting Back on ... Reform and PCMA. The briefing featured ... prescription drug abuse and fraud. The Centers for Disease ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
(Date:9/29/2014)... BEIJING , Sept. 29, 2014  Following US and ... accelerator, the China Food and Drug Administration (CFDA) has ... in the country. According to the International ... people are diagnosed with cancer every year in ... types including lung, gastric, colorectal, liver and esophageal cancers ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3
... DIEGO, Dec. 18 Ambrx Inc. today announced ... with Merck & Co. Inc. to,develop a novel ... Factor 21 (FGF-21) for the treatment of type ... The collaboration utilizes Ambrx,s proprietary protein technology,ReCODE(TM), ...
... Epeius Biotechnologies,Corporation announced today that the company ... Rexin-G(R) from the Philippine Bureau of Food ... lead product as a safe,and effective treatment ... as a tumor-targeted anticancer agent, that actively ...
Cached Medicine Technology:Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc. 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 3
(Date:9/30/2014)... IL (PRWEB) September 30, 2014 From ... will be exhibiting at the 2014 SHSMD Connections Annual ... Society for Healthcare Strategy & Market Development (SHSMD) is ... healthcare marketing, public relations and communications, and strategic planning ... , About SHSMD Connections , The conference is a ...
(Date:9/30/2014)... placebo did not reduce hospital length of stay, intensive ... the risk of death at 6 months among patients ... to a study published in JAMA . The ... its presentation at the European Society of Intensive Care ... low vitamin D levels has been confirmed in patients ...
(Date:9/30/2014)... New Albany, IN (PRWEB) September 30, 2014 ... Dr. Ron Receveur encourages all persons who have ... gum disease in a recent blog post. , The ... reminds those with dental implants that if they don’t ... in the same way people lose their natural teeth: ...
(Date:9/30/2014)... 2014 Youth Town’s annual BBQ/Music Festival ... to 2 p.m. at the Youth Town campus (3641 ... sponsors this family-oriented festival, which will offer music, food ... feature a car show, arts and crafts fair, music, ... games. Also, Lightning McQueen and Mater from the hit ...
(Date:9/30/2014)... September 30, 2014 “Biology and ... Bryan W. Brickner, “and it’s about naming rights.” ... Science , new on the Bryan William Brickner ... the National Institutes of Health (PubMed). The post ... sleep disturbances, REM transitions, aging with THC, the ...
Breaking Medicine News(10 mins):Health News:MMS, Inc. (Medical Marketing Service) to Attend the 2014 SHSMD Connections Annual Conference in October 2Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2
... men and women who engage in high levels of ... knees and increasing their risk for osteoarthritis, according to ... the Radiological Society of North America (RSNA). "Our ... may be at greater risk for developing knee abnormalities ...
... Medical Center researchers have found that informed adults can ... findings, available online and in the December issue of ... caregivers of asthmatic children who have received specialized ... emergency room visits and missed adult workdays. "Childhood ...
... , ... of General Dentistry (AGD) announces that Aria Irvani, DDS, of Orange county CA, received ... excellence in dental education.,To accomplish this, Dr. Irvani completed 1,100 hours of approved continuing ... skills and techniques. , ...
... for something leads to more self-defensive finger pointing, study finds ... is a contagious one, a new study reports, even when ... see someone blame someone else for a problem, even if ... in blaming others, too. , "When we see others ...
... ... for viable affordable alternative care. Affordable Acupuncture Scottsdale answers the call. , ... (PRWEB) November 29, 2009 -- ... been met with enthusiasm and gratitude. Its increasing popularity and rapid success can be ...
... affect circadian rhythm, , FRIDAY, Nov. 27 (HealthDay News) -- ... on the fritz could be a factor in the development ... from the examination of the genetic makeup of 152 children ... mood swings, and 140 children without the disorder. They linked ...
Cached Medicine News:Health News:Too much physical activity may lead to arthritis 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Bipolar Disorder May Be Tied to Body Clock 2
... the new large power line ... function as both cordless AND ... in flexibility. Its the versatility ... with the security of the ...
... is a full-function, electric powered system ... a wide range of surgical applications ... Bone Orthopedics, Orthopedic Trauma, Oral and ... Surgery. Because it is a complete, ...
The 7500 Drill/Reamer operates at two speeds for multiple applications, which is automatically controlled by the 16 different coupler attachments. The drill reamer can be used for, but is not limited...
... Surgical's Breakthrough in Battery Powered Orthopedic Systems., ... revolutionary new addition to the Hall® Surgical ... Battery System is the first and only ... the market. It is a full-function orthopedic ...
Medicine Products: